Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Dabigatran: review of pharmacology and management of bleeding complications of this novel oral anticoagulant.

Ganetsky M, Babu KM, Salhanick SD, Brown RS, Boyer EW.

J Med Toxicol. 2011 Dec;7(4):281-7. doi: 10.1007/s13181-011-0178-y. Review.

2.

Dabigatran for stroke prevention in nonvalvular atrial fibrillation: focus in the geriatric population.

Brunetti L, Chen C, White J.

Consult Pharm. 2014 Mar;29(3):169-78. doi: 10.4140/TCP.n.2014.169. Review.

PMID:
24589766
3.

Dabigatran: an oral direct thrombin inhibitor for use in atrial fibrillation.

Bendel SD, Bona R, Baker WL.

Adv Ther. 2011 Jun;28(6):460-72. doi: 10.1007/s12325-011-0025-1. Epub 2011 Apr 26. Review.

PMID:
21533567
4.

Dabigatran: a new chapter in anticoagulation.

Ahmed S, Levin V, Malacoff R, Martinez MW.

Cardiovasc Hematol Agents Med Chem. 2012 Jun;10(2):116-23. Review.

PMID:
22480286
5.

Implications of Dabigatran, a direct thrombin inhibitor, for oral surgery practice.

Davis C, Robertson C, Shivakumar S, Lee M.

J Can Dent Assoc. 2013;79:d74. Review.

6.

[Direct oral thrombin inhibitor, "dabigatran"].

Yasaka M.

Nihon Rinsho. 2013 Jan;71(1):113-8. Review. Japanese.

PMID:
23631181
7.

Pharmacokinetic and clinical implications of dabigatran use in severe renal impairment for stroke prevention in nonvalvular atrial fibrillation.

Mack DR, Kim JJ.

Ann Pharmacother. 2012 Jul-Aug;46(7-8):1105-10. doi: 10.1345/aph.1R057. Epub 2012 Jul 3. Review.

PMID:
22764329
8.

The acute management of haemorrhage, surgery and overdose in patients receiving dabigatran.

Alikhan R, Rayment R, Keeling D, Baglin T, Benson G, Green L, Marshall S, Patel R, Pavord S, Rose P, Tait C.

Emerg Med J. 2014 Feb;31(2):163-8. doi: 10.1136/emermed-2012-201976. Epub 2013 Feb 22. Review.

9.

Review of recently approved alternatives to anticoagulation with warfarin for emergency clinicians.

Brem E, Koyfman A, Foran M.

J Emerg Med. 2013 Jul;45(1):143-9. doi: 10.1016/j.jemermed.2012.11.032. Epub 2013 Jan 30. Review.

PMID:
23375217
10.

Hospital-based clinical implications of the novel oral anticoagulant, dabigatran etexilate, in daily practice.

Wilcox R, Pendleton RC, Smock KJ, Rodgers GM.

Hosp Pract (1995). 2011 Aug;39(3):23-34. doi: 10.3810/hp.2011.08.576. Review.

PMID:
21881389
11.

Advances in anticoagulation: focus on dabigatran, an oral direct thrombin inhibitor.

Augoustides JG.

J Cardiothorac Vasc Anesth. 2011 Dec;25(6):1208-12. doi: 10.1053/j.jvca.2011.08.005. Epub 2011 Oct 7. Review.

PMID:
21982327
12.

Dabigatran and kidney disease: a bad combination.

Knauf F, Chaknos CM, Berns JS, Perazella MA.

Clin J Am Soc Nephrol. 2013 Sep;8(9):1591-7. doi: 10.2215/CJN.01260213. Epub 2013 Jul 18. Review.

13.

Novel oral anticoagulants for stroke prevention in patients with atrial fibrillation.

Berman JP, Halperin JL.

Hosp Pract (1995). 2013 Feb;41(1):37-48. doi: 10.3810/hp.2013.02.1006. Review.

PMID:
23466966
14.

[Dabigatran, a new oral anticoagulant].

Uchiyama S.

Brain Nerve. 2011 Apr;63(4):411-5. Review. Japanese.

PMID:
21441645
15.

Preventing cardioembolic stroke in atrial fibrillation with dabigatran.

Weimar C, Hohnloser SH, Eikelboom JW, Diener HC.

Curr Neurol Neurosci Rep. 2012 Feb;12(1):17-23. doi: 10.1007/s11910-011-0229-4. Review.

PMID:
21960064
16.

[Dabigatran and emergency operation on a peritonitis patient].

Ilmakunnas M, Louhimo J, Lassila R.

Duodecim. 2012;128(7):753-7. Review. Finnish.

PMID:
22612026
17.

The pharmacology and therapeutic use of dabigatran etexilate.

Sarah S.

J Clin Pharmacol. 2013 Jan;53(1):1-13. doi: 10.1177/0091270011432169. Epub 2013 Jan 24. Review.

PMID:
23400738
18.

[Waiting for the new oral anticoagulants: questions and answers about dabigatran].

Verdecchia P, Agnelli G.

G Ital Cardiol (Rome). 2013 Jan;14(1):35-45. doi: 10.1714/1207.13371. Review. Italian.

PMID:
23258203
19.

Warfarin versus dabigatran: comparing the old with the new.

Abraham ME, Marcy TR.

Consult Pharm. 2012 Feb;27(2):121-4. doi: 10.4140/TCP.n.2012.121. Review.

PMID:
22330953
20.

Dabigatran, intracranial hemorrhage, and the neurosurgeon.

Awad AJ, Walcott BP, Stapleton CJ, Yanamadala V, Nahed BV, Coumans JV.

Neurosurg Focus. 2013 May;34(5):E7. doi: 10.3171/2013.2.FOCUS1323. Review.

PMID:
23634926
Items per page

Supplemental Content

Write to the Help Desk